Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs

被引:152
作者
Thews, Oliver
Gassner, Birgit
Kelleher, Debra K.
Schwerdt, Gerald
Gekle, Michael
机构
[1] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, D-55099 Mainz, Germany
[2] Univ Wurzburg, Inst Physiol, D-97070 Wurzburg, Germany
来源
NEOPLASIA | 2006年 / 8卷 / 02期
关键词
P-glycoprotein; acidity; chemotoxicity; intracellular Ca2+ concentration; protein kinase C;
D O I
10.1593/neo.05697
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The expression and activity of P-glycoprotein (pGP) play a role in the multidrug resistance of tumors. Because solid-growing tumors often show pronounced hypoxia or extracellular acidosis, this study attempted to analyze the impact of an acidic environment on the expression and activity of pGP and on the cytotoxicity of chemotherapeutic agents. For this, prostate carcinoma cells were exposed to an acidic extracellular environment (pH 6.6) for up to 24 hours. pGP activity was more than doubled after 3 to 6 hours of incubation in acidic medium, whereas cellular pGP expression remained constant, indicating that increased transport rate is the result of functional modulation. In parallel, the cytotoxic efficacy of daunorubicin showed pronounced reduction at low pH, an effect that was reversible on coincubation with a pGP inhibitor. A reduction of intracellular Ca2+ concentration by 35% under acidic conditions induced a higher transport rate of pGP, an effect comparable to that found on inhibition of protein kinase C (PKC). These data indicate that pGP activity is increased by acidic pH presumably as a result of lowered intracellular calcium levels and inhibition of PKC. These findings may explain the reduced cytotoxicity of chemotherapeutic agents in hypoxic/acidic tumors.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 53 条
[1]
P-glycoprotein: from genomics to mechanism [J].
Ambudkar, SV ;
Kimchi-Sarfaty, C ;
Sauna, ZE ;
Gottesman, MM .
ONCOGENE, 2003, 22 (47) :7468-7485
[2]
Batra S, 1996, INT J CANCER, V68, P644, DOI 10.1002/(SICI)1097-0215(19961127)68:5<644::AID-IJC15>3.0.CO
[3]
2-1
[4]
BUSH RS, 1978, BRIT J CANCER, V37, P302
[5]
CHAMBERS TC, 1993, J BIOL CHEM, V268, P4592
[6]
Multidrug resistance ABC transporters [J].
Chang, G .
FEBS LETTERS, 2003, 555 (01) :102-105
[7]
Chaplin DJ, 1998, MED RAD DIA IMG, P133
[8]
TEMPORAL HETEROGENEITY IN MICROREGIONAL ERYTHROCYTE FLUX IN EXPERIMENTAL SOLID TUMORS [J].
CHAPLIN, DJ ;
HILL, SA .
BRITISH JOURNAL OF CANCER, 1995, 71 (06) :1210-1213
[9]
Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools [J].
Chen, JSK ;
Agarwal, N ;
Mehta, K .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (03) :237-247
[10]
Comerford KM, 2002, CANCER RES, V62, P3387